Skip to main content
Log in

Impact of omeprazole on the plasma clearance of methotrexate

  • Short Communication
  • Omeprazole, Methotrexate, Pharmacokinetics, Kidney
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Omeprazole inhibits the gastric hydrogen pump and is an effective treatment for peptic ulcers. Methotrexate is a chemotherapeutic agent that inhibits dihydrofolate reductase and is eliminated by a hydrogen-ion-dependent mechanism in the kidney. We present evidence that omeprazole inhibits methotrexate clearance and may result in potentially toxic methotrexate levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Abelson HT, Fosburg MT, Beardsley GP, et al (1983) Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. J Clin Oncol 1: 208

    Google Scholar 

  2. Ackland S, Schilsky R (1987) High-dose methotrexate: a critical reappraisal. J Clin Oncol 5: 2017

    Google Scholar 

  3. Adams MH, Ostrosky JD, Kirkwood CF (1988) Therapeutic evaluation of omeprazole. Clin Pharm 7: 725

    Google Scholar 

  4. Antonell M, Morelan L, Brick J (1991) Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. Am J Med 90: 295

    Google Scholar 

  5. Basin KS, Escalante A, Beardmore TD (1991) Severe pancytopenia in a patient taking low dose methotrexate and probenecid. J Rheumatol 18: 609

    Google Scholar 

  6. Besseghir K, Mosig D, Roch-Ramel F (1989) Transport of methotrexate by the in vitro isolated rabbit proximal tubule. J Pharmacol Exp Ther 250: 688–695

    Google Scholar 

  7. Dent J (1990) Australian clinical trials of omeprazole in the management of reflux oesophagitis. Digestion 47: 69

    Google Scholar 

  8. Doucet A, Marsy S (1987) Characterization of K-ATPase activity in distal nephron: stimulation by potassium depletion. Am J Physiol 253: 418

    Google Scholar 

  9. Ensminger WD (1984) Clinical pharmacology of folate analogs. In: Sirotnok FM, Burchall JJ, Ensminger WB, Montgomery JA (eds) Folate antagonists as therapeutic agents, vol 2. Academic Press. Orlando, pp 133–163

    Google Scholar 

  10. Garg LC, Narang N (1988) Ouabain-insensitive K-adenosine triphosphatase in distal nephron segments of the rabbit. J Clin Invest 81: 1204–1208

    Google Scholar 

  11. Isacoff W, Morrison R, Aroesty J, Welles K, Block J, Lincoln T (1977) Pharmacokinetics of high dose methotrexate with citrovorum factor rescue. Cancer Treat Rep 61: 1665

    Google Scholar 

  12. Iven H, Brasch H (1988) The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits. Cancer Chemother Pharmacol 21: 337

    Google Scholar 

  13. Jorizzo JL, White WL, Wise CM, Zanolli MD, Sherertz EF (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behcet's disease. J Am Acad Dermatol 24: 973

    Google Scholar 

  14. Lind T, Cederberg C, Idstrom JP, Lonroth H, Olbe L, Lundell L (1991) 24-Hour intragastric acidity and plasma gastrin during longterm treatment with omeprazole or ranitidine in patients with reflux esophagitis. Scand J Gastroenterol 26: 620

    Google Scholar 

  15. Link M, Goorin A, Miser A, Green A, et al. (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314: 1600

    Google Scholar 

  16. Lippens RJJ (1984) Methotrexate: pharmacology and pharmacokinetics. Am J Pediatr Hematol Oncol 6: 379–395

    Google Scholar 

  17. Lundell L (1990) Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Digestion 47: 72

    Google Scholar 

  18. Neirenberg D (1983) Competitive inhibition of methotrexate accumulation in rabbit kidney slices by non-steroidal anti-inflammatory drugs. J Pharmacol Exp Ther 226: 1

    Google Scholar 

  19. Olsen E (1991) The pharmacology of methotrexate. J Am Acad Dermatol 25: 306

    Google Scholar 

  20. Olsen SL, O'Connell JB, Bristow MR, Renlund DG (1990) Methotrexate as an adjunct in the treatment of persistent mild cardiac allograft rejection. Transplantation 50: 773

    Google Scholar 

  21. Planelles G, Anagnostopoulos T, Cheval L, Doucet A (1991) Biochemical and functional characterization of H(+)-K(+)-ATPase in distal amphibian nephron. Am J Physiol 260: 806

    Google Scholar 

  22. Regardh CG, Andersson T, Lagerstrom PO, Lundborg P, Skanberg I (1990) The pharmacokinetics of omeprazole in humans — a study of single intravenous and oral doses. Ther Drug Monit 12: 163

    Google Scholar 

  23. Rose B (1984) Clinical physiology of acid-base and electrolyte disorders, 2nd edn. McGraw-Hill, New York, pp 106–107

    Google Scholar 

  24. Scully CJ, Anderson CJ, Cannon GW (1991) Long-term methotrexate therapy for rheumatoid arthritis. Semin Arthritis Rheum 20: 317

    Google Scholar 

  25. Stewart KA, Mackenzie AH, Clough JD, Wilke WS (1991) Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Semin Arthritis Rheum 20: 332

    Google Scholar 

  26. Webster GF, Razsi LK, Sanchez M, Shupack JL (1991) Weekly low-dose methotrexate therapy for cutaneous sarcoidosis. J Am Acad Dermatol 24: 451

    Google Scholar 

  27. Wingo C (1989) Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. Functional evidence for proton-potassium-activated adenosine triphosphatase. J Clin Invest 84: 361

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reid, T., Yuen, A., Catolico, M. et al. Impact of omeprazole on the plasma clearance of methotrexate. Cancer Chemother. Pharmacol. 33, 82–84 (1993). https://doi.org/10.1007/BF00686028

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686028

Keywords

Navigation